Caris Life Sciences vs MacroGenics

Caris Life Sciences vs MacroGenics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and MacroGenics on 49/100.

Caris Life Sciences logo
Caris Life SciencesCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Try Caris Life Sciences
MacroGenics logo
MacroGenicsBiopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
Try MacroGenics

Where each one leads

Caris Life Sciences

  • our overall score: 59/100 against 49/100
  • agent readiness: 47/100 against 35/100
  • domain rating: 63/100 against 50/100
  • funding raised: $700M against $13.5M

MacroGenics

Leads on none of the measures we hold for both companies.

At a glance

MeasureCaris Life SciencesMacroGenics
What it isCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
CategoryBiotech, MedTech, HealthTech, GenomicsBiotech, MedTech, HealthTech, Genomics
Sells toBusiness modelB2BB2B
OfferingServicesSoftware
Founded20082000
HeadquartersIrving, United StatesRockville, United States
StatusActiveActive

Size, funding and growth

MeasureCaris Life SciencesMacroGenics
Employees1,659Not published
Total funding$700M$13.5M
Latest roundSeries DSeries A
Valuation$7.8BNot published
LinkedIn followers77,698Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCaris Life SciencesMacroGenics
StartupHub scoreOur 0-100 rating59/10049/100
Traction60/10036/100
TeamNot published70/100
Search visibility22/10012/100
Quality78/10058/100
Agent readinessHow well an AI agent can read and act on the siteD (47/100)F (35/100)
Domain ratingLink authority, 0-10063/10050/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCaris Life SciencesMacroGenics
HostingSelf ManagedGoogle Cloud
CMSWordPressWordPress
FrameworksNot detectedJquery
AnalyticsGoogle Tag ManagerGoogle Analytics 4

Caris Life Sciences vs MacroGenics: common questions

Which is better, Caris Life Sciences or MacroGenics?

On our 0-100 score Caris Life Sciences rates higher (59/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.

How do Caris Life Sciences and MacroGenics compare on the numbers?

Caris Life Sciences leads on our overall score (59/100 against 49/100), agent readiness (47/100 against 35/100), domain rating (63/100 against 50/100), funding raised ($700M against $13.5M).

Read the full Caris Life Sciences review and pricing or the MacroGenics review and pricing. You can also browse other Caris Life Sciences alternatives we track.